This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
APEN Aperçu des actions
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy.
| Score flocon de neige | |
|---|---|
| Évaluation | 0/6 |
| Croissance future | 2/6 |
| Performances passées | 0/6 |
| Santé financière | 5/6 |
| Dividendes | 0/6 |
Apollo Endosurgery, Inc. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$10.00 |
| Plus haut sur 52 semaines | US$10.30 |
| Plus bas sur 52 semaines | US$3.49 |
| Bêta | 2.32 |
| 1Variation sur 1 mois | 0.50% |
| Variation sur 3 mois | 1.11% |
| Variation sur 1 an | 67.79% |
| 3Variation sur 3 ans | 360.83% |
| Variation sur 5 ans | 70.94% |
| Évolution depuis l'introduction en bourse | -17.76% |
Nouvelles et mises à jour récentes
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Apr 03
Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?
Nov 30Recent updates
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Apr 03Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?
Nov 30Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?
Aug 05Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings
Aug 04Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Mar 02Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?
Aug 04Apollo Endosurgery: New Management Bounce Makes Weight Loss Specialist A Buy
Jun 28Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?
May 05Apollo Endosurgery EPS beats by $0.05, beats on revenue
May 04A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)
Mar 24What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?
Mar 03Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares
Feb 10We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt
Jan 31Assessing Apollo Endosurgery
Dec 27If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%
Dec 27Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?
Dec 01Apollo Endosurgery EPS beats by $0.10, beats on revenue
Nov 05Rendement pour les actionnaires
| APEN | US Medical Equipment | US Marché | |
|---|---|---|---|
| 7D | 0.8% | 1.0% | 1.1% |
| 1Y | 67.8% | 26.6% | 32.2% |
Rendement vs Industrie: APEN exceeded the US Medical Equipment industry which returned -13.3% over the past year.
Rendement vs marché: APEN exceeded the US Market which returned -11.4% over the past year.
Volatilité des prix
| APEN volatility | |
|---|---|
| APEN Average Weekly Movement | 0.5% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 14.7% |
| 10% least volatile stocks in US Market | 3.1% |
Cours de l'action stable: APEN has not had significant price volatility in the past 3 months.
Volatilité au fil du temps: APEN's weekly volatility has decreased from 12% to 1% over the past year.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 2005 | 202 | Chas McKhann | www.apolloendo.com |
Apollo Endosurgery, Inc. Résumé des fondamentaux
| APEN statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$579.72m |
| Bénéfices(TTM) | -US$39.84m |
| Recettes(TTM) | US$76.86m |
7.5x
Ratio P/S-14.6x
Ratio P/ELe site APEN est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| APEN compte de résultat (TTM) | |
|---|---|
| Recettes | US$76.86m |
| Coût des recettes | US$34.43m |
| Marge brute | US$42.43m |
| Autres dépenses | US$82.27m |
| Les revenus | -US$39.84m |
Derniers bénéfices déclarés
Dec 31, 2022
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | -0.69 |
| Marge brute | 55.20% |
| Marge bénéficiaire nette | -51.84% |
| Ratio dettes/capitaux propres | 164.7% |
Quelles ont été les performances à long terme de APEN?
Voir les performances historiques et les comparaisons